InsidersTradesSigma
Track the Diamyd Medical Aktiebolag stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Market capitalisation: €158.4m. The latest transaction was disclosed on 27 July 2026 (Purchase). Among the most active insiders: Anders Essen-Möller. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Diamyd Medical Aktiebolag 是一家瑞典生物制药公司，专注于开发 1 型糖尿病治疗方法。它在斯德哥尔摩证券交易所上市。